Rare diseases, chronic diseases, infectious disease and oncology. Communicable and non-communicable. LCM™ address deficits in primary care for a defined population with a specific shared disease or medical condition, procedure, or care episode. PCPs gain more patient-specific disease intelligence from multiple longitudinal timepoints via LCM™.

LCM™ enables a primary care doctor, group of primary health care providers or primary care hospital system to incentivize preemptive health and preventive diagnostics for improving the overall quality of care, including advanced primary care services, care coordination and health outcomes for a defined group of patients, thereby reducing care fragmentation and unnecessary costs for patients and the health system. LCM™ enables robust patient-centric screening with active surveillance for primary care.

LCM™ enables a state or community-based organization for high-throughput and scalable population-based screening and monitoring. LCM™ is a preventive diagnostic tool for public health initiatives.

LCM™ can generate population-based risk assessments for health plan providers. LCM™ is a patient-specific incentivizing tool for active longitudinal monitoring of primary health to identify any risks proactively before it reaches secondary/tertiary care.

LCM™ is intended to lower healthcare costs by identifying primary care issues BEFORE it enters secondary/tertiary stages. This enables reduction of healthcare spend via better biomarker surveillance in primary care. By insituting LCM™ as standard of practice in PCP settings, the number of avoided cases that were identified early as a result of LCM™ is equivalent to the cost-savings of early intervention in proactive primary care (as opposed to reactive secondary/tertiary care).